Nykredit A S Acquires New Holdings in Agilent Technologies, Inc. $A

Posted by George Bondi on Sep 6th, 2026

Nykredit A S bought a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 70,199 shares of the medical research company’s stock, valued at approximately $9,325,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC grew its position in shares of Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares in the last quarter. Jones Financial Companies Lllp raised its position in shares of Agilent Technologies by 15.9% in the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after buying an additional 769 shares in the last quarter. Geneos Wealth Management Inc. raised its position in shares of Agilent Technologies by 54.8% in the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after buying an additional 212 shares in the last quarter. Acadian Asset Management LLC boosted its stake in Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after buying an additional 758 shares during the period. Finally, Sivia Capital Partners LLC bought a new stake in Agilent Technologies during the second quarter valued at $273,000.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock opened at $150.60 on Friday. The firm has a market capitalization of $42.46 billion, a PE ratio of 29.65, a price-to-earnings-growth ratio of 2.30 and a beta of 1.24. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $163.75. The business’s 50-day moving average price is $142.27 and its 200-day moving average price is $127.87.

Agilent Technologies (NYSE:A – Get Free Report) last issued its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same quarter in the prior year, the firm earned $1.37 earnings per share. Agilent Technologies’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have weighed in on A. Sanford C. Bernstein upped their target price on Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. Robert W. Baird lifted their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Thursday, May 28th. Finally, TD Cowen lifted their target price on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research report on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $170.33.

Check Out Our Latest Stock Report on A

About Agilent Technologies

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Nykredit A S Acquires New Holdings in Agilent Technologies, Inc. $A

Agilent Technologies Price Performance

Analyst Ratings Changes

About Agilent Technologies

Further Reading

You might be interested in: